Researchers identify how prostate tumors alter immune microenvironment to resist treatment

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new pathway used by prostate tumors to suppress the immune system. This pathway reshapes the tumor microenvironment, enabling the tumors to resist treatment. This finding could provide new targets for therapeutic intervention in prostate cancer.

Originally published by gnews